Kewal Handa
-
Feb 12 2013
KEWAL HANDA OF PFIZER SAYS Indian Pharma Industry is likely to post a GDP growth of 9.2 % in FY 2011 & 11% in 2012
KEWAL HANDA OF PFIZER SAYS Indian Pharma Industry is likely…
Read more
- 1
- 2
Breaking News
- ticket title
- Shortage of Trained Officer & Lack of Skilled & Competent Visiting Officers to medical devices manufacturers factories expose the technical knowledge bankruptcy of the Regulatory Mechanism
- Dr Dilip Surana, CMD, Micro Labs Limited featured in the prestigious Healthcare Super Brands Asia
- The remarkable recovery of a Sundarbans’ resident from a devastating tiger attack
- Hearzap Strengthens Market Position with 51% Acquisition of Speech and Hearing Care
- Fischer Medical Ventures Ltd Partners with Bio Angle Vacs Sdn Bhd’s in Science, Technology and Marketing to bring their Breakthrough Vaccine Products
- India Leadership Conclave 2024 Power Brand Awards conferred to top Business Leaders
- Healthcare Innovation in India to Double, $60 Billion Opportunity by 2028 Pharma services and healthtech account for 80% of the market,Biotech and Medtech emerge as greenshoots
- 1 in 5 people diagnosed with diabetes in the last 5 years are in the age group 18-30 years
- Remedium Lifecare Limited bags “Best Returns to the Investors Award” at Brandscouncil Ratings & Medilinks India Awards 2023
- Largest kidney stone removed using a new-minimally invasive Holmium laser with Moses 2.0 technology
